» Articles » PMID: 33715304

Caring for Cancer Patients During COVID-19 Global Pandemic: Risk Factors and Precautionary Principle

Overview
Publisher Wiley
Specialty General Medicine
Date 2021 Mar 14
PMID 33715304
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The current global pandemic COVID-19 challenges oncologists to reorganise cancer care in order to strikingly reduce hospital visits and admissions. Cancer patients are more susceptible to infections and likely to get severe consequences compared with other patients. Health-care facility services are quickly changing their systems and workflow in response to the global pandemic COVID-19 crisis. These alterations mitigate infection risks and give profound effects on crucial aspects of care, including patients with cancer. Here, we discuss the current situations and a roadmap for cancer care during the COVID-19 crisis. In the prevalence of global cancer and higher transmission of pandemic COVID-19, there is an urgent need to realise the effect of SARS-CoV-2 infection and their related life-threatening outcomes specifically for cancer patients.

Citing Articles

"You matter": patients perceptions and disparities about  cancer care and telehealth during and after COVID-19 pandemic.

Mohanna M, Herran M, Dominguez B, Sabbagh S, Msheik A, Itani M Support Care Cancer. 2024; 32(4):236.

PMID: 38506939 PMC: 10954847. DOI: 10.1007/s00520-024-08433-2.


Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19: analysis of the nationwide BSMO-COVID registry providing lessons for the future.

Geukens T, Brandao M, Laenen A, Collignon J, van Marcke C, Louviaux I ESMO Open. 2022; 7(6):100610.

PMID: 36356416 PMC: 9639795. DOI: 10.1016/j.esmoop.2022.100610.


Health influence of SARS-CoV-2 (COVID-19) on cancer: a review.

Parise R, Li Y, Nadar R, Ramesh S, Ren J, Govindarajulu M Acta Biochim Biophys Sin (Shanghai). 2022; 54(10):1395-1405.

PMID: 36269132 PMC: 9828497. DOI: 10.3724/abbs.2022147.


Cytochrome c: Using Biological Insight toward Engineering an Optimized Anticancer Biodrug.

Delinois L, De Leon-Velez O, Vazquez-Medina A, Velez-Cabrera A, Marrero-Sanchez A, Nieves-Escobar C Inorganics (Basel). 2022; 9(11).

PMID: 35978717 PMC: 9380692. DOI: 10.3390/inorganics9110083.


Cancer Patients' Experiences with Telehealth before and during the COVID-19 Pandemic in British Columbia.

Izadi-Najafabadi S, McQuarrie L, Peacock S, Halperin R, Lambert L, Mitton C Curr Oncol. 2022; 29(6):4199-4211.

PMID: 35735444 PMC: 9222084. DOI: 10.3390/curroncol29060335.


References
1.
Mao R, Liang J, Shen J, Ghosh S, Zhu L, Yang H . Implications of COVID-19 for patients with pre-existing digestive diseases. Lancet Gastroenterol Hepatol. 2020; 5(5):425-427. PMC: 7103943. DOI: 10.1016/S2468-1253(20)30076-5. View

2.
Abdel-Rahman O, Fouad M . Risk of pneumonitis in cancer patients treated with immune checkpoint inhibitors: a meta-analysis. Ther Adv Respir Dis. 2016; 10(3):183-93. PMC: 5933609. DOI: 10.1177/1753465816636557. View

3.
Di Saverio S, Pata F, Gallo G, Carrano F, Scorza A, Sileri P . Coronavirus pandemic and colorectal surgery: practical advice based on the Italian experience. Colorectal Dis. 2020; 22(6):625-634. DOI: 10.1111/codi.15056. View

4.
Blanco-Colino R, Soares A, Kuiper S, Zaffaroni G, Pata F, Pellino G . Surgical Training During and After COVID-19: A Joint Trainee and Trainers Manifesto. Ann Surg. 2020; 272(1):e24-e26. DOI: 10.1097/SLA.0000000000003929. View

5.
Desai A, Sachdeva S, Parekh T, Desai R . COVID-19 and Cancer: Lessons From a Pooled Meta-Analysis. JCO Glob Oncol. 2020; 6:557-559. PMC: 7193801. DOI: 10.1200/GO.20.00097. View